Keyword: Enbrel

News

The Biosimilar Market

07.02.2014 - Pharmaceuticals - Many biologic drug developers can be pleased with how well their products have performed in the market place. Blockbuster products such as Abbvie's (ex-Abbott)...

News

Amgen Buys Onyx for $10.4 Billion

26.08.2013 - Amgen struck a deal to buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion on Sunday, as it moves to restock its product pipeline in response to declining sales of...

News

Amgen Biosimilar Push Takes Aim at Blockbusters

07.02.2013 - Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...

News

Amgen Q3 Profits Up

24.10.2012 - Amgen on Tuesday reported higher-than-expected third-quarter profit in its first full quarter under Chief Executive Robert Bradway and it raised its full-year earnings and revenue...